Editorial: Multidisciplinary treatment and precision medicine for acral and mucosal melanoma
- PMID: 38873257
- PMCID: PMC11169852
- DOI: 10.3389/fonc.2024.1429030
Editorial: Multidisciplinary treatment and precision medicine for acral and mucosal melanoma
Keywords: acral melanoma; immunotherapy; melanoma; mucosal melanoma; targeted therapy.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Multidisciplinary treatment and precision medicine for acral and mucosal melanoma
Similar articles
-
Multidisciplinary approach and treatment of acral and mucosal melanoma.Front Oncol. 2024 Feb 26;14:1340408. doi: 10.3389/fonc.2024.1340408. eCollection 2024. Front Oncol. 2024. PMID: 38469235 Free PMC article. Review.
-
Targeted Therapy and Immunotherapy for Melanoma in Japan.Curr Treat Options Oncol. 2019 Jan 24;20(1):7. doi: 10.1007/s11864-019-0607-8. Curr Treat Options Oncol. 2019. PMID: 30675668 Free PMC article. Review.
-
Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions.Front Immunol. 2021 Jun 4;12:680407. doi: 10.3389/fimmu.2021.680407. eCollection 2021. Front Immunol. 2021. PMID: 34149718 Free PMC article. Review.
-
Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma.J Immunother Cancer. 2020 Mar;8(1):e000341. doi: 10.1136/jitc-2019-000341. J Immunother Cancer. 2020. PMID: 32209601 Free PMC article.
-
The efficacy of anti-PD-1 agents in acral and mucosal melanoma.Cancer. 2016 Nov 15;122(21):3354-3362. doi: 10.1002/cncr.30259. Epub 2016 Aug 17. Cancer. 2016. PMID: 27533633 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources